株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ドイツにおけるオーソバイオロジクス市場の見通し

Germany Orthobiologics Market Outlook to 2021

発行 GlobalData 商品コード 297049
出版日 ページ情報 英文 66 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
ドイツにおけるオーソバイオロジクス市場の見通し Germany Orthobiologics Market Outlook to 2021
出版日: 2015年09月11日 ページ情報: 英文 66 Pages
概要

当レポートでは、ドイツにおけるオーソバイオロジクス市場について、代用骨移植片、関節内補充薬、自家骨移植片、骨成長刺激装置のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • オーソバイオロジクス市場の区分
  • 本レポートで対象としている市場の定義

第3章 ドイツにおけるオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • Medtronic, Inc.
  • DePuy Companies
  • Biomet, Inc.
  • Stryker Corporation
  • Sanofi
  • Baxter International Inc.
  • DJO Finance LLC
  • Arthrex, Inc.
  • Ferring International Center S.A.
  • Wright Medical Group, Inc.
  • 生化学工業
  • Anika Therapeutics, Inc.
  • NuVasive, Inc.
  • curasan AG
  • Alphatec Holdings, Inc.
  • Globus Medical, Inc.

第5章 パイプライン製品

第6章 財務取引の情勢

  • 資本取引
  • 提携

第7章 最近の動向

  • 財務発表
  • 製品情報

第8章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC1061DB

GlobalData's new report, "Germany Orthobiologics Market Outlook to 2021", provides key market data on the Germany Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the Germany Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, Germany

  • 3.1. Orthobiologics Market, Germany, Revenue ($m), 2007-2014
  • 3.2. Orthobiologics Market, Germany, Revenue ($m), 2014-2021
    • 3.2.1. Bone Grafts and Substitutes Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Bone Growth Stimulators Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Viscosupplementation Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Bone Grafts and Substitutes Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 3.2.5. Bone Growth Stimulators Market, Germany, Revenue ($m), by Segment, 2014-2021
    • 3.2.6. Viscosupplementation Market, Germany, Revenue ($m), by Segment, 2014-2021
  • 3.3. Orthobiologics Market, Germany, Volume (Units), 2007-2014
  • 3.4. Orthobiologics Market, Germany, Volume (Units), 2014-2021
    • 3.4.1. Bone Grafts and Substitutes Market, Germany, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Bone Growth Stimulators Market, Germany, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Viscosupplementation Market, Germany, Volume (Units), by Segment, 2007-2014
    • 3.4.4. Bone Grafts and Substitutes Market, Germany, Volume (Units), by Segment, 2014-2021
    • 3.4.5. Bone Growth Stimulators Market, Germany, Volume (Units), by Segment, 2014-2021
    • 3.4.6. Viscosupplementation Market, Germany, Volume (Units), by Segment, 2014-2021
  • 3.5. Orthobiologics Market, Germany, Average Price ($), 2007-2021
  • 3.6. Orthobiologics Market, Germany, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Orthobiologics Market, Germany, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in Germany, Orthobiologics Market

  • 4.1. Medtronic plc
    • 4.1.1. Company Overview
  • 4.2. DePuy Companies
    • 4.2.1. Company Overview
  • 4.3. Baxter International Inc.
    • 4.3.1. Company Overview
  • 4.4. Arthrex, Inc.
    • 4.4.1. Company Overview
  • 4.5. DJO Finance LLC
    • 4.5.1. Company Overview
  • 4.6. Seikagaku Corporation
    • 4.6.1. Company Overview
  • 4.7. Sanofi
    • 4.7.1. Company Overview
  • 4.8. Anika Therapeutics, Inc.
    • 4.8.1. Company Overview
  • 4.9. Bioventus LLC
    • 4.9.1. Company Overview
  • 4.10. Ossatec Benelux B.V.
    • 4.10.1. Company Overview
  • 4.11. Biomet, Inc. (Inactive)
    • 4.11.1. Company Overview
  • 4.12. Cellumed Co. Ltd.
    • 4.12.1. Company Overview
  • 4.13. Stryker Corporation
    • 4.13.1. Company Overview
  • 4.14. Qingdao Haitao Biochemical Co.,Ltd
    • 4.14.1. Company Overview
  • 4.15. Mylan N.V.
    • 4.15.1. Company Overview
  • 4.16. Patterson Medical Holdings, Inc.
    • 4.16.1. Company Overview
  • 4.17. Bloomage Freda Biopharm Co., Ltd
    • 4.17.1. Company Overview

5. Orthobiologics Market Pipeline Products

6. Recent Developments

  • 6.1. Corporate Communications
    • 6.1.1. Aug 27, 2015: ESC Congress 2015: BIOTRONIK Announces CE Approval and Pilot Study Results for BioMonitor 2
  • 6.2. Strategy And Business Planning
    • 6.2.1. Jun 24, 2015: LifeVac Registered With UK Ministry of Health

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Market Modeling and Forecasting
    • 7.1.5. Company Share Analysis
    • 7.1.6. Distribution Share Analysis
  • 7.2. Expert Panel
  • 7.3. GlobalData Consulting
  • 7.4. Contact Us
  • 7.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Orthobiologics Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 10: Orthobiologics Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 11: Bone Grafts and Substitutes Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 12: Bone Growth Stimulators Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 13: Viscosupplementation Market, Germany, Volume (Units), Historic, 2007-2014
  • Table 14: Bone Grafts and Substitutes Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 15: Bone Growth Stimulators Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 16: Viscosupplementation Market, Germany, Volume (Units), Forecast, 2014-2021
  • Table 17: Orthobiologics Market, Germany, Average Price ($) Historic, 2007-2014
  • Table 18: Orthobiologics Market, Germany, Average Price ($), Forecast, 2014-2021
  • Table 19: Orthobiologics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Orthobiologics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Orthobiologics Market Pipeline Products
  • Table 22: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Orthobiologics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Orthobiologics Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 10: Orthobiologics Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 11: Bone Grafts and Substitutes Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 12: Bone Growth Stimulators Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 13: Viscosupplementation Market, Germany, Volume (Units), Historic, 2007-2014
  • Figure 14: Bone Grafts and Substitutes Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 15: Bone Growth Stimulators Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 16: Viscosupplementation Market, Germany, Volume (Units), Forecast, 2014-2021
  • Figure 17: Orthobiologics Market, Germany, Company Share (%) 2014
  • Figure 18: GlobalData Epidemiology-Based Forecasting Model
  • Figure 19: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 20: Primary Interviews by Participant Type (%)
Back to Top